The Richmond Group

Laboratorios Richmond is a leading Argentine pharmaceutical company that specializes in the development, manufacturing, and commercialization of high-complexity medicines. The company maintains a significant presence in therapeutic areas such as HIV/AIDS, oncology, cardiology, and infectious diseases, offering a robust portfolio of generic and biosimilar products. Richmond gained international prominence for its role in the regional production of the Sputnik V COVID-19 vaccine and has since continued to expand its biotechnology infrastructure with the development of advanced manufacturing facilities. Publicly traded on the Buenos Aires Stock Exchange, the company operates across multiple Latin American markets and is recognized for its commitment to increasing access to essential therapies through scientific innovation and local production.